Small molecule-based Lifespan extension therapy: Gremlin-1 promotes longevity via its target gene, 8/May/2015, 10.16 am

MiRNA-based therapy for Alzheimer’s disease: MiRNA-433 ameliorates cognitive deficits in Alzheimer’s disease patients via up regulation of its target gene, 7/May/2014, 23.14
May 7, 2015
Natural product-based therapy for T2DM: Berberine, an isoquinoline derivative alkaloid isolated from medicinal herbs, enhances insulin secretion by increasing glucagon-like peptide-1 secretion via up regulation of its target gene, 8/May/2015, 10.41
May 8, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Small molecule-based Lifespan extension therapy: Gremlin-1 promotes longevity via its target gene, 8/May/2015, 10.17 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that Gremlin-1 may extend the lifespan of mammals. Thus, pharmacological formulations encompassing “Gremlin-1 activators” may be used to extend the life-span of an individual.

Undisclosed information: How Gremlin-1 extends the lifespan of an individual. 

Comments are closed.